Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia, 23:1261-1274, 2021.
A major challenge to the treatment of advanced prostate cancer (PCa) is the development of resistance to androgen-deprivation therapy (ADT) and chemotherapy…
